Abstract:Vascular disrupting agents disrupt tumour vessels, blocking the nutritional and oxygen supply tumours need to thrive. This is achieved by damaging the endothelium lining of blood vessels, resulting in red blood cells (RBCs) entering the tumour parenchyma. RBCs present in the extracellular matrix are exposed to external stressors resulting in biochemical and physiological changes. The detection of these changes can be used to monitor the efficacy of cancer treatments. Spectroscopic photoacoustic (PA) imaging is an ideal candidate for probing RBCs due to their high optical absorption relative to surrounding tissue. The goal of this work is to use PA imaging to monitor the efficacy of the vascular disrupting agent 5,6‐Dimethylxanthenone‐4‐acetic acid (DMXAA) through quantitative analysis.4T1 breast cancer cells were injected subcutaneously into the left hind leg of eight BALB/c mice. After 10 days, half of the mice were treated with 15 mg/kg of DMXAA and the other half were injected with saline. All mice were imaged using the VevoLAZR X PA system before treatment, 24 and 72 hours after treatment. The imaging was done at six wavelengths and linear spectral unmixing was applied to the PA images to quantify three forms of hemoglobin (oxy, deoxy and met‐hemoglobin). After imaging, tumours were histologically processed and H&E and TUNEL staining were used to detect the tissue damage induced by the DMXAA treatment.The total hemoglobin concentration remained unchanged after treatment for the saline treated mice. For DMXAA treated mice, a 10% increase of deoxyhemoglobin concentration was detected 24 hrs after treatment and a 22.6% decrease in total hemoglobin concentration was observed by 72 hrs. A decrease in the PA spectral slope parameters was measured 24 hours after treatment. This suggests that DMXAA induces vascular damage, causing red blood cells to extravasate. Furthermore, H&E staining of the tumour showed areas of bleeding with erythrocyte deposition. These observations are further supported by the increase in TUNEL staining in DMXAA treated tumours, revealing increased cell death due to vascular disruption. This study demonstrates the capability of PA imaging to monitor tumour vessel disruption by the vascular disrupting agent DMXAA.This article is protected by copyright. All rights reserved.

A Comparison of Tumor Demarcation Potential for Various Hematoporphyrin Derivatives and Phtalocyanine Using Laser-Induced Fluorescence

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Fluorescence Detection of Protoporphyrin Ix in Living Cells: A Comparative Study on Single- and Two-Photon Excitation

Photodynamic Effect Of Chlorophyll Derivative With Pulsed Copper Vapor Laser On Human Rectal-Carcinoma Invitro

An Organophosphorescence Probe with Ultralong Lifetime and Intrinsic Tissue Selectivity for Specific Tumor Imaging and Guided Tumor Surgery

Accuracy and Outcome of Sonographically Guided Intra‐articular Sodium Hyaluronate Injections in Patients With Osteoarthritis of the Hip

Tumor-specific Fluorescence Activation of Rhodamine Isothiocyanate Derivatives.

Effect of Photosensitizer Concentration and Treatment Time on Fluorescence Diagnosis

Synthesis and evaluation of novel fluorinated hematoporphyrin ether derivatives for photodynamic therapy

Use of photoacoustic imaging for monitoring vascular disrupting cancer treatments

A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment

Depth-resolved imaging of photosensitizer in the rodent brain using fluorescence laminar optical tomography.

Synthesis, Radiolabeling, Biodistribution and Fluorescent Imaging of Histidine-Coupled Hematoporphyrin

Supplementary Data from A Near-Infrared Phosphorescent Nanoprobe Enables Quantitative, Longitudinal Imaging of Tumor Hypoxia Dynamics During Radiotherapy

Comparison of cRGDfK Peptide Probes with Appended Shielded Heptamethine Cyanine Dye ( s775z ) for Near Infrared Fluorescence Imaging of Cancer

The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP® Peptides) Conjugated with Different Fluorescent Dyes

AIE-Fluorescent TPENC12 Nanoliposome: Construction and Characterization of Optical Properties

Pharmacokinetics and Biodistribution of Near-Infrared Fluorescence Polymeric Nanoparticles

Study of Serum Fluorescence and Raman Spectra for Diagnosis of Cancer

Tumor-Targeted Fluorescence Imaging and Mechanisms of Tumor Cell-Derived Carbon Nanodots